InMed Pharmaceuticals Inc. - Common Shares, no par value (INM)
CUSIP: 457637601
Q3 2022 13F Holders as of 30 Sep 2022
- Type / Class
- Equity / Common Shares, no par value
- Shares outstanding
- 804,525
- Total 13F shares
- 132,993
- Share change
- +132,993
- Total reported value
- $876,125
- Price per share
- $6.58
- Number of holders
- 8
- Value change
- +$876,125
- Number of buys
- 8
Quarterly Holders Quick Answers
What is CUSIP 457637601?
CUSIP 457637601 identifies INM - InMed Pharmaceuticals Inc. - Common Shares, no par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
- Newer quarter: Q4 2022
Recent filing periods for CUSIP 457637601:
Top shareholders of INM - InMed Pharmaceuticals Inc. - Common Shares, no par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
130%
|
956,118
|
$450,000 | — | 30 Jun 2022 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
6.7%
|
49,700
|
$23,000 | — | 30 Jun 2022 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
6.5%
|
48,281
|
$23,000 | — | 30 Jun 2022 | |
| Bruce Colwill |
3/4/5
|
CFO |
—
class O/S missing
|
11,515
|
$10,294 | — | 24 Jan 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.9%
|
13,905
|
$6,000 | — | 30 Jun 2022 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.8%
|
12,966
|
$6,000 | — | 30 Jun 2022 | |
| Creative Planning |
13F
|
Company |
1.5%
|
10,832
|
$5,000 | — | 30 Jun 2022 | |
| TD Waterhouse Canada Inc. |
13F
|
Company |
0.29%
|
2,130
|
$1,264 | — | 30 Jun 2022 | |
| Federation Des Caisses Desjardins du Quebec |
13F
|
Individual |
0.07%
|
511
|
$240 | — | 30 Jun 2022 | |
| Catherine Sazdanoff |
3/4/5
|
Director |
—
class O/S missing
|
29,091
|
— | — | 29 Dec 2021 | |
| Adam D. Cutler |
3/4/5
|
Director |
—
class O/S missing
|
16,122
|
— | — | 24 Jan 2022 | |
| Mr. William J. Garner |
3/4/5
|
Director |
—
class O/S missing
|
16,122
|
— | — | 24 Jan 2022 |
Institutional Holders of InMed Pharmaceuticals Inc. - Common Shares, no par value (INM) as of Q3 2022
As of 30 Sep 2022,
InMed Pharmaceuticals Inc. - Common Shares, no par value (INM) was held by
8 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
132,993 shares.
The largest 8 holders included
ARMISTICE CAPITAL, LLC, SABBY MANAGEMENT, LLC, MILLENNIUM MANAGEMENT LLC, BANK OF AMERICA CORP /DE/, UBS Group AG, Tower Research Capital LLC (TRC), MORGAN STANLEY, and Federation des caisses Desjardins du Quebec.
This page lists
8
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2022 vs Q4 2024 Across Filers
Q4 2024 holders
0
Q3 2022 holders
8
Holder diff
8
| Investor | Q4 2024 Shares | Q3 2022 Shares | Share Diff | Share Chg % | Q4 2024 Value $ | Q3 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.